Log in to save to my catalogue

Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic revi...

Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic revi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1201c3a6e5104506957b3cf97db1fe10

Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic review and Bayesian network meta-analysis

About this item

Full title

Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic review and Bayesian network meta-analysis

Publisher

England: BioMed Central Ltd

Journal title

Systematic Reviews, 2025-03, Vol.14 (1), p.59-16, Article 59

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chinese classical prescriptions (CCPs) are commonly utilized in China as an adjuvant treatment for dilated cardiomyopathy (DCM). Nevertheless, there was insufficient systematic evidence data to show the advantages of CCPs plus current conventional therapy (CT) against DCM. This network meta-analysis (NMA) sought to evaluate and prioritize the six d...

Alternative Titles

Full title

Efficacy and safety of Chinese classical prescriptions for dilated cardiomyopathy: a systematic review and Bayesian network meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1201c3a6e5104506957b3cf97db1fe10

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1201c3a6e5104506957b3cf97db1fe10

Other Identifiers

ISSN

2046-4053

E-ISSN

2046-4053

DOI

10.1186/s13643-025-02802-6

How to access this item